Skip to main content

CORRECTION article

Front. Immunol.

Sec. Viral Immunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1598312

Corrigendum: Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals

Provisionally accepted
Flávia Lopes Adami Flávia Lopes Adami 1Mateus Vidigal de Castro Mateus Vidigal de Castro 1Bianca da Silva Almeida Bianca da Silva Almeida 1Isabela Pazotti Daher Isabela Pazotti Daher 1Marcio Massao Yamamoto Marcio Massao Yamamoto 1Keity Souza Santos Keity Souza Santos 1Mayana Zatz Mayana Zatz 1Michel Satya Naslavsky Michel Satya Naslavsky 1Daniela Santoro Rosa Daniela Santoro Rosa 2Edecio Cunha-Neto Edecio Cunha-Neto 1Vivian Leite de Oliveira Vivian Leite de Oliveira 1Jorge Kalil Jorge Kalil 1Silvia Beatriz Boscardin Silvia Beatriz Boscardin 1*
  • 1 University of São Paulo, São Paulo, Brazil
  • 2 Federal University of São Paulo, São Paulo, São Paulo, Brazil

This article is a correction to:

  1. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals

    1. Read original article

The final, formatted version of the article will be published soon.

    Select one of your emails

    You have multiple emails registered with Frontiers:

    Notify me on publication

    Please enter your email address:

    If you already have an account, please login

    You don't have a Frontiers account ? You can register here

    Corrigendum on: Adami FL, de Castro MV, Almeida BdS, Daher IP, Yamamoto MM, Souza Santos K, Zatz M, Naslavsky MS, Rosa DS, Cunha-Neto E, de Oliveira VL, Kalil J and Boscardin SB (2024) Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals. Front. Immunol. 15:1396603.doi: 10.3389/fimmu.2024.1396603 In the published article, there was an error in Supplementary Figure 2. Specifically, the graph depicting HCoV-NL63, originally intended for panel B, was mistakenly replaced with the HCoV-OC43 graph, which was already present in panel D. This resulted in a duplication of the HCoV-OC43 data in both panels B and D. In addition, the HCoV-HKU1 and HCoV-OC43 graphs were misplaced in panels C and D, respectively. The correct order is HCoV-OC43 (C) and HCoV-HKU1 (D).The corrected Supplementary Figure 2 including the original captions appear below.

    Keywords: Seasonal coronavirus, COVID-19, humoral immunity, Cross reactivity, RBD protein

    Received: 22 Mar 2025; Accepted: 25 Mar 2025.

    Copyright: © 2025 Adami, de Castro, Almeida, Daher, Yamamoto, Santos, Zatz, Naslavsky, Rosa, Cunha-Neto, de Oliveira, Kalil and Boscardin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Silvia Beatriz Boscardin, University of São Paulo, São Paulo, Brazil

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    People also looked at

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more